Team 6 – Patents

NEWS

To read our last papers,
please see PubMed website

logo PubMed
photo_groupe_ONC-ZOOM
You are here: Home > Onco and NeuroChemistry > PATENTS

ONCO & NEUROCHEMISTRY

PATENTS

2018

Carato P, Descamps F, El Bakali J, Evrard C, Gay M, Melnyk P, Renault N, Sergeant N, Vingtdeux V.
Polyamino biaryl compounds and their use. EP 18305932.8.

2017

Tavis J-E, Cotelle P, Bailly F.
N-Hydroxyisoquinolindione inhibitors of HBV replication. PCT/US2017/022738

2015

Melnyk P, LeFur N, Gay M, Sergeant N, Buée L.
Novel 1,4-bis(3-aminopropyl)piperazine derivative and its use . EP 15305384.8.

2014

Melnyk P, Vermersch P, Carato P, Vanteghem-Oxombre B, Zephir H, Donnier-Maréchal M.
Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases. EP14305919.4.

Melnyk P, Carato P, Burlet S, Nguyen T-H, Verwaerde P, Sergeant N, Estrella C.
Beta and gamma-carbolines derivatives for the treatment of neurodegenerative diseases.
PCT/EP2014/063771.

2013

Melnyk P, Carato P, Burlet S, Nguyen T-H, Verwaerde P, Sergeant N, Estrella C.
γ-carbolines derivatives for the treatment of neurodegenerative diseases. EP13305927.9

Melnyk P, Carato P, Burlet S, Nguyen T-H, Verwaerde P, Sergeant N, Estrella C.
β -carbolines derivatives for the treatment of neurodegenerative diseases. EP13305928.7

Melnyk P, Carato P, Burlet S, Nguyen T-H, Verwaerde P, Sergeant N, Estrella C.
Na-substituted carbolines derivatives for the treatment of neurodegenerative diseases. EP13305929.5

2012

Barrier M, Buée L, Burlet S, Delacourte A, Estrella C, Melnyk P, Sergeant N, Verwaerde P.
Sulfate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d] imidazol-2-amine, preparation thereof and use of the same. EP12 306690.4

Bailly F, Billamboz M, Christ F, Cotelle P, Debyser Z, Lion C, Suchaud V.
2-hydroxyisoquinoline-1,3(2h,4h)-diones and related compounds useful as HIV replication inhibitors (PCT Int. Appl. (2012), WO 2012085003 A1 20120628)

Willand N, Brodin P, Agouridas-Dutot L, Deprez B, Baulard A.
Composés de type spiroisoxazoline ayant une activité potentialisatrice de l’activité d’un antibiotique-composition et produits pharmaceutiques comprenant de tels composés. FR12/03549